Heather Preston, M.D.

Partner & Managing Director, TPG Biotech

Heather Preston is Managing Director at TPG Biotech. Prior to joining TPG Biotech in 2005, Dr. Preston worked in investment banking at JP Morgan Partners, served as an Entrepreneur-in-Residence with New Enterprise Associates, and was a leader of the pharmaceutical and medical products consulting practice at McKinsey & Co. She has an undergraduate degree in biochemistry from the University of London, a medical degree from the University of Oxford, and a post-doctoral fellowship in molecular biology at the Dana Farber Cancer Institute, Harvard University.

She completed her training in Internal Medicine at the Massachusetts General Hospital and then sub-specialized in Gastroenterology and Hepatology at University of California, San Francisco. During her academic career, Dr. Preston was the recipient of a Fulbright Scholarship, a Fulbright Cancer Research Scholarship, a Harlech Scholarship and a Science and Engineering Research Council Post-Doctoral Fellowship Award. In addition to Albireo, Dr. Preston serves on the Board of Directors of Alder Biotherapeutics (NASDAQ: ALDR) and numerous private companies.

Team members

David Chiswell, Ph.D.

Chairman of the Board, Albireo; Chief Executive Officer, Kymab

Julia R. Brown

Former Executive Vice President and Advisor to the CEO, Amylin Pharmaceuticals (retired)

Michael Gutch, Ph.D.

Chief Business Officer and Chief Financial Officer, Entasis Therapeutics

Roger A. Jeffs, Ph.D.

Former President and co-CEO, United Therapeutics (retired)

Heather Preston, M.D.

Partner & Managing Director, TPG Biotech

Davey S. Scoon

Chair of the Board of Trustees, Allianz Global Investors

Ron Cooper

President and Chief Executive Officer